G1 Therapeutics, Inc.   Report issue

Founded: Durham North Carolina United States (2008)

Organization Overview

First Clinical Trial
2014
NCT02243150
First Marketed Drug
2021
trilaciclib
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

G1 THERAP | G1 Therapeutics, Inc.